| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/16/2008 | EP1943249A1 Inhibitors of the hiv integrase enzyme |
| 07/16/2008 | EP1943221A1 Piperazine amidines as antiviral agents |
| 07/16/2008 | EP1943219A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/16/2008 | EP1942899A2 Mitotic kinesin inhibitors |
| 07/16/2008 | EP1942896A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/16/2008 | EP1709044B1 Oxazolidinone-quinolone hybrid antibiotics |
| 07/16/2008 | EP1466527B1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1318835B1 Use of imidazoquinolinamines as adjuvants in dna vaccination |
| 07/16/2008 | CN101223170A 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of TPL2 kinase and methods of making and using the same |
| 07/16/2008 | CN101223169A Pyrrole(2,3-b)pyridine derivatives protein kinase inhibitors |
| 07/16/2008 | CN101223168A Heterocyclic JANUS kinase 3 inhibitors |
| 07/16/2008 | CN101223167A Novel heteroaryl fused cyclic amines |
| 07/16/2008 | CN101223166A Thiazolyl MGLUR5 antagonists and methods for their use |
| 07/16/2008 | CN101223162A Indolylmaleimide derivatives |
| 07/16/2008 | CN101222924A Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 07/16/2008 | CN101220030A A kind of multi-ring heterocyclic compound, preparation method and application thereof |
| 07/16/2008 | CN101220029A Cerium color reagent azo fluorine arsine ¿CDBN<Y>, synthesis and application thereof |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101220027A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 07/16/2008 | CN101220026A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
| 07/16/2008 | CN100402529C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402515C Substituted phthalides as anti-convulsive drugs |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399860 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/15/2008 | US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 07/15/2008 | US7399769 3-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,5-a]pyridine-6-carboxylic acid methyl ester; gamma aminobutyric acid GABA A alpha 5 receptor inverse agonist; relatively free of activity at GABA A alpha 1, alpha 2 and alpha 3 receptor binding; cognition activator, Alzheimer's disease; |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399432 Charge transport compositions and electronic devices made with such compositions |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/10/2008 | WO2008083356A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008082490A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082381A1 Immune response modifier formulations containing oleic acid and methods |
| 07/10/2008 | WO2008081914A1 Novel aminopyrimidine derivative as plk1 inhibitor |
| 07/10/2008 | WO2008081910A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | WO2008081266A1 Compounds for the treatment or prevention of infection by flaviviridae |
| 07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 07/10/2008 | WO2008064107A3 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008064107A2 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008021038A3 Pyridobenzazepine compounds and methods for inhibiting mitotic progression |
| 07/10/2008 | WO2007115821A3 Organic compounds |
| 07/10/2008 | US20080167443 Novel chelating agents and highly luminescent and stable chelates and their use |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167336 Azaadamantane derivatives and methods of use |
| 07/10/2008 | US20080167304 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | CA2710051A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | CA2672960A1 Novel jnk inhibitors |
| 07/10/2008 | CA2672940A1 Novel jnk inhibitors |
| 07/10/2008 | CA2671710A1 Conglomerates of tenatoprazole potassium salts |
| 07/10/2008 | CA2668738A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | CA2643679A1 Immune response modifier formulations containing oleic acid and methods |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1940845A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 07/09/2008 | EP1940841A2 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 07/09/2008 | EP1940840A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 07/09/2008 | EP1940839A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha |
| 07/09/2008 | EP1940838A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940837A2 Imidazopyridine compounds |
| 07/09/2008 | EP1940836A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 07/09/2008 | EP1940835A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 07/09/2008 | EP1940834A2 Amorphous and crystalline forms of 9-hydroxy-risperidone (paliperidone) |
| 07/09/2008 | EP1940819A1 Phosphodiesterase 10 inhibitors |
| 07/09/2008 | EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/09/2008 | EP1940412A2 Novel opioid antagonists |
| 07/09/2008 | EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1940296A2 Chemical compounds |
| 07/09/2008 | EP1819704B1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 07/09/2008 | EP1687305B1 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 07/09/2008 | EP1390367B1 DIHYDROIMIDAZO 5,1-A -$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | EP1219624B1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 07/09/2008 | CN101218241A Pyrrolopyridine derivatives as protein kinase inhibitors |
| 07/09/2008 | CN101218240A Process for preparing bicyclic compounds |
| 07/09/2008 | CN101218239A Process for preparing bicyclic compounds |
| 07/09/2008 | CN101218238A Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 07/09/2008 | CN101217958A Inhibitors of AKT activity |
| 07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
| 07/09/2008 | CN101215285A Polyhydroxy substituted octahydroindolizidine and synthesis method thereof |
| 07/09/2008 | CN100400538C 5ht2c receptor agonists for the treatment of diabetes and obesity |
| 07/09/2008 | CN100400515C Isoquinoline derivatives and methods of use thereof |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/08/2008 | US7396940 Randomized library of 500-10000 different compounds immobilized on a solid support; biosynthessis by the Suzuki reaction using a platinum catalyst and boronic acid derivative; antagonists against chemoattractant receptors such as chemokine receptors, particularlyCCR6; antiinflammatory agents |
| 07/08/2008 | US7396932 Fusing a N-phenyl-C-leaving group-C-carbonyl- or oxycarbonylhydrazide with a 1-(p-nitrophhenyl)-3-halo-tetrahydro-2-piperidone; subsequent reactions include reduction and amidation of the nitro group and amidation of carbonyl or ester group; final products include factor Xa inhibitors |
| 07/08/2008 | US7396931 Clopidogrel sulfate by reacting a first solvent solution of clopidogrel with sulfuric acid, adding a second solvent to precipitate the salt, and filtering; first and second solvents are acetone and diisopropyl ether or dichloromethane and either diisopropyl ether, cyclohexane or ethyl acetate |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396837 topoisomerase I inhibitors; stimulate topoisomerase I-mediated DNA cleavage and their cytotoxic potential; antitumor agent; prostate gland, ovaries, colon cancer; marine alkaloids |